• 한국미생물·생명공학회지
• /
• 제7권1호
• /
• pp.1-8
• /
• 1979

혈액 및 생체반응물질등에 함유된 미량의 glucose를 효소적으로 간편하게 측량하기 위하여 먼저 고가의 glucose oxidase를 고정화 시켰다. 전리 방사선조사에 의하여 이 효소를 쉽게 고정화 시킬수 있는 방법과 그 알맞는 조건 및 높은 잔여 활성에 관한 결과는 다음과 같다. 1) 여러가지 monomer 및 polymer의 combination 중에서 AA-Bis, NK ester 23G, 물 (1:1:2)에 가용성 효소 1ml를 고정화 시켰을 경우를 비롯하여 GOD의 잔여활성이 50%이상인 여러 monomer Combination 찾았다 2) Carrier의 방사선중합에 필요한 선량은 100 krad 이상 이였으나, 400~500krad가 적당하였고, solvent는 toluene, n-haxane, petoleum ether chloroform 등을 이용할 때 고정화된 GOD의 잔여 활성 및 이화학적 성장이 좋았다. 3) GOD 고정화에 이용될 수 있는 완충 용액은 tris-glycerol buffer (pH 7.0)가 phosphate (pH 7.0) 보다 높은 활성을 보여 주었다. 4) 고정화된 GOD의 최적 pH는 6.0~6.5 또 온도는 30~4$0^{\circ}C$로서 가용성 효소보다 작용범위가 넓었고, pH 및 온도의 변화도 완만하였다. The author acknowledges with gratitude financial assistance from International Atomic Energy Agency, Vienna, Austria and also sincerely thanks Dr. K. Kawashima and his colleagues, National Food Research Institute, Tokyo, Iapan for encouragement and assistance.

• Molecular & Cellular Toxicology
• /
• 제2권4호
• /
• pp.236-243
• /
• 2006

Microarray analysis of gene expression has become a powerful approach for exploring the biological effects of drugs, particularly at the stage of toxicology and safety assessment. Acetaminophen (APAP) has been known to induce necrosis in liver, but the molecular mechanism involved has not been fully understood. In this study, we investigated gene expression changes of APAP using microarray technology. APAP was orally administered with a single dose of 50 mg/kg or 500 mg/kg into ICR mice and the animals were sacrificed at 6, 24 and 72 h of APAP administration. Serum biochemical markers for liver toxicity were measured to estimate the maximal toxic time and hepatic gene expression was assessed using high-density oligonucleotide microarrays capable of determining the expression profile of >30,000 well-substantiated mouse genes. Significant alterations in gene expression were noted in the liver of APAP-administered mice. The most notable changes in APAP-administered mice were the expression of genes involved in apoptosis, cell cycle, and calcium signaling pathway, cystein metabolism, glutatione metabolism, and MAPK pathway. The majority of the genes upregulated included insulin-like growth factor binding protein 1, heme oxygenase 1, metallothionein 1, S100 calcium binding protein, caspase 4, and P21. The upregulation of apoptosis and cell cycle-related genes were paralleled to response to APAP. Most of the affected gene expressions were returned to control levels after 72 hr. In conclusion, we identified potential hepatotoxicity makers, and these expressions profiling lead to a better understanding of the molecular basis of APAP-induced hapatotoxicity.

• Pediatric Infection and Vaccine
• /
• 제15권2호
• /
• pp.115-120
• /
• 2008

목 적 : 본 시판 후 조사는 한국인에게 투여한 A형 간염 백신(GlaxoSmithKline Biologicals' $Havrix^{TM}$)의 안전성과 반응원성을 평가하기 위해 한국에서 실시되었다. 방 법 : 6세 미만의 1,122명의 피험자를 포함하는 총 1,188명의 건강한 피험자들이 2005년 4월부터 2006년 1월까지 등록되어 A형 간염 백신 1회를 접종 받았다. 백신 접종 후 4일 동안 명시된 증상 보고와 31일의 추적 기간 동안 명시되거나 되지 않은 증상 보고를 위해 피험자 또는 피험자의 부모에게 증상 기록 카드가 제공되었다. 결 과 : 증상 기록 카드를 돌려준 피험자는 568명이었고, 반면에 620명의 피험자는 증상 기록 카드를 돌려 주지 않았다. 증상 기록 카드를 돌려준 피험자들 중에 9.9%가 국소 증상을 보고하였고, 14.3%가 전신 증상을 보고하였다. 증상 기록 카드를 돌려주지 않은 피험자들 가운데 1.6%가 국소 증상을 보고하였으며 8.4%가 전신 증상을 보고하였다. 이 두 군 사이에는 국소 증상과 전신 증상 보고의 빈도에서는 통계적으로 유의한 차이가 있었다. 명시되지 않은 증상은 13.2%의 피험자에서 최소한 한 번 이상 보고 되었다. 결 론 : A형 간염백신($Havrix^{TM}$) 은 접종 후 내약성과 안전성이 있다고 사료된다. 백신 접종 후 증상 기록 카드를 제공함으로써 신뢰할 수 있는 백신 접종 후 이상 반응의 정보를 알 수 있었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권5호
• /
• pp.2169-2177
• /
• 2014

Matrine, a main active component extracted from dry roots of Sophora flavecens, has been reported to exert antitumor effects on A549 human non-small lung cancer cells, but its mechanisms of action remain unclear. To determine effects of matrine on proliferation of A549 cells and assess possible mechanisms, MTT assays were employed to detect cytotoxicity, along with o flow cytometric analysis of DNA content of nuclei of cells following staining with propidium iodide to analyze cell cycle distribution. Western blotting was performed to determined expression levels of Bax, Bcl-2, VEGF and HDAC1, while a microarray was used to assessed changes of miRNA profiles. In the MTT assay, matrine suppressed growth of human lung cancer cell A549 in a dose- and timedependent manner at doses of 0.25-2.5 mg/ml for 24h, 48h or 72h. Matrine induced cell cycle arrest in G0/G1 phase and decreased the G2/M phase, while down-regulating the expression of Bcl2 protein, leading to a reduction in the Bcl-2/Bax ratio. In addition, matrine down regulated the expression level of VEGF and HDAC1 of A549 cells. Microarray analysis demonstrated that matrine altered the expression level of miRNAs compared with untreated control A549 cells. In conclusion, matrine could inhibit proliferation of A549 cells, providing useful information for understanding anticancer mechanisms.

• Journal of Korean Neurosurgical Society
• /
• 제52권6호
• /
• pp.534-540
• /
• 2012

Objective : Brainstem arteriovenous malformation (AVM) is rare and radiosurgical management is complicated by the sensitivity of the adjacent neurological structures. Complete obliteration of the nidus is not always possible. We describe over 20 years of radiosurgical procedures for brainstem AVMs, focusing on clinical outcomes and radiosurgical techniques. Methods : Between 1992 and 2011, the authors performed gamma knife radiosurgery (GKRS) in 464 cerebral AVMs. Twenty-nine of the 464 patients (6.3%) reviewed had brainstem AVMs. This series included sixteen males and thirteen females with a mean age of 30.7 years (range : 5-71 years). The symptoms that led to diagnoses were as follows : an altered mentality (5 patients, 17.3%), motor weakness (10 patients, 34.5%), cranial nerve symptoms (3 patients, 10.3%), headache (6 patients, 20.7%), dizziness (3 patients, 10.3%), and seizures (2 patients, 6.9%). Two patients had undergone a previous nidus resection, and three patients had undergone a previous embolization. Twenty-four patients underwent only GKRS. With respect to the nidus type and blood flow, the ratio of compact type to diffuse type and high flow to low flow were 17 : 12 and 16 : 13, respectively. In this series, 24 patients (82.8%) had a prior hemorrhage. The mean target volume was 1.7 $cm^3$ (range 0.1-11.3 $cm^3$). The mean maximal and marginal radiation doses were 38.5 Gy (range 28.6-43.6 Gy) and 23.4 Gy (range 18-27 Gy), and the mean isodose profile was 61.3% (range 50-70%). Results : Twenty-four patients had brainstem AVMs and were followed for more than 3 years. Obliteration of the AVMs was eventually documented in 17 patients (70.8%) over a mean follow-up period of 77.5 months (range 36-216 months). With respect to nidus type and blood flow, the obliteration rate of compact types (75%) was higher than that of diffuse types (66.7%), and the obliteration rate of low flow AVMs (76.9%) was higher than that of high flow AVMs (63.6%) (p<0.05). Two patients (6.9%) with three hemorrhagic events suffered a hemorrhage during the follow-up period. The annual bleeding rate of AVM after GKRS was 1.95% per year. No adverse radiation effects or delayed cystic formations were found. Conclusion : GKRS has an important clinical role in treatment of brainstem AVMs, which carry excessive surgical risks. Angiographic features and radiosurgical techniques using a lower maximal dose with higher isodose profiles are important for lesion obliteration and the avoidance of complications.

• 환경영향평가
• /
• 제14권5호
• /
• pp.347-353
• /
• 2005

The risk assessment is the qualitative or quantitative evaluation of the risk posed to human health and the environment by the actual or potential presence or release of hazardous substances, pollutants or contaminants. The environmental impact assessment (EIA) is assessed by the environmental criteria, and risk assessment is assessed by the risk rate. Risk rate based on dose-response values may not be easy to apply on regulatory basis like EIA for uncertainty. Internationally there is an example of OECD program. Risk assessment of High Production Volume (HPV) Chemicals has started since the OECD Program with the 1990 Council Act on the Co-operative Investigation and Risk Reduction of Existing Chemicals. These HPV chemicals include all chemicals produced or imported at levels greater than 1,000 tonnes per year in at least one Member country or in the European Union region. The SIDS called the Screening Information Data Set is regarded as the minimum information needed to assess an HPV chemical to determine whether any further work should be carried out or not. All the data elements of SIDS including assessment for environment and health are prepared as three formats of the full SIDS Dossier, the SIDS Initial Assessment Report (SIAR), and the SIDS Initial Assessment Profile (SIAP) of an HPV chemical. In 1998 the global chemical industry through the International Council of Chemical Associations (ICCA) has joined to work with OECD. The OECD has assessed approximately 1,000 chemicals from 1991 through 2004 with ICCA. Till the February of 2005, 592 chemicals of those chemicals completed SIDS reports. Member countries have been targeted the goal of 1,000 new chemicals from 2005 to 2010 and Korea shared 36 chemicals from the 1,000 new chemicals. Currently Korea has completed SIDS reports of 7 chemicals among sponsored 24 chemicals. In conclusion SIDS project will be linked to national program for outputs application with more reliable production. Both the OECD and industry will carry out their commitment to complete assessments for more and the remaining chemicals assessment. The major outputs will contribute to cope with international chemical management.

• Radiation Oncology Journal
• /
• 제20권4호
• /
• pp.375-380
• /
• 2002

목적 : 사용하기 편리한 주기적 QA용 필름 선량측정 시스템을 개발하고자 하였다. 대상 및 방법 : OCF 선량측정 시스템(One Click Film Dosimetry system)은 주기적 정도관리를 신속히 처리할 수 있도록 포그 값 설정 및 H&D 환산, 각도 조절, 영상 중심점 자동 설정, 대칭도 자동 계산, 관심이 있는 위치에서 프로파일을 볼 수 있도록 하는 기능, 3차원 선량 분포 영상 실시간 구현 등이 가능하도록 고안하였다. 결과 : 주기적 정도관리에 자주 사용되는 기능으로 영상의 중심점, 포그 값 설정과 H&D 환산(Background/H&D Correction), 대칭도, 등선량 분포도 그리고, 3차원 선량 분포 영상 실시간 구현 및 임의의 지점에 대한 프로파일을 한 번의 클릭으로 볼 수 있었다. 결론 : OCF 선량측정 시스템은 임상에서 정도관리를 수행하는 절차가 상품화된 필름 선량측정 프로그램에 비해 간단한 절차로 신속한 결과를 보여주었다. 앞으로 세련된 사용자 인터페이스 환경설계와 주변장치 인터페이스 같은 세부적인 기능 강화를 통해서 실제 임상에서 여러 분야에서 유용하게 이용할 수 있음을 보였다.

• 대한수의학회지
• /
• 제39권2호
• /
• pp.257-266
• /
• 1999

Ivermectin is a widely used broad spectrum antiparasitic agent in veterinary medicine. In this work, we examined the pharmacokinetic parameters and the tissue residue profile of a new injectable formulation of ivermectin developed for pigs. The plasma ivermectin levels reached the peak at about 9 and 2 hours after the administrations in young and adult pigs, respectively. But the elimination half-life (3-3.5 days) and the $C_{max}$ values (24~28 ng/ml) were not significantly different between young and adult pig groups. When compared to the reference formulation, the $C_{max}$ of test formulation was higher and $T_{1/2}$ values were shorter than those of the reference formulation, respectively. The tissue residue levels were dose- and time-dependent and were higher in the liver and fat, than in the other tissues such as the injection sites, the kidney, intestine, muscle, plasma (4~74 ng/g) at the 7th day after the administration of both formulations of ivermectin. Then, the mean tissue ivermectin levels at the 21st day after the administration in all the tissues decreased to 7.4 and 25% of the 7th day levels in the test and reference formulations, respectively. In general, the tissue levels of ivermectin in the animals treated with the test formulation decreased more rapidly than those with the reference formulation. The tissue to plasma distribution ratio (T/P ratio) of ivermectin was higher in the liver and fat than other tissues. The T/P ratio in the liver of animals treated with the test formulation was somewhat higher than that in the animals treated with the reference formulation. Taken together, the results of pharmacokinetic and tissue residue studies indicate that the test formulation of ivermectin for subcutaneous injection is comparable to the reference formulation, but unique in that it has higher peak plasma concentrations, shorter elimination half-life and higher T/P ratio in the liver than the reference formulation.

• Journal of Animal Science and Technology
• /
• 제48권5호
• /
• pp.663-670
• /
• 2006

국내에서 제조된 서방출형 유전자재조합 돼지 성장호르몬 (porcine somatotropin; pST)이 돼지의 성장과 등지방두께에 미치는 영향을 구명하기 위해 평균체중이 78kg인 랜드레이스 거세돈 48두를 공시하여 대조구, 4:1제형 rpST구 (6회 투여), 1:1제형 rpST구 (4회 투여), 4:1제형 rpST구 (4회 투여)에 각각 12두씩 배치하였다. 대조구는 pST를 투여하지 않았고, rpST 처리구는 1주일에 1회, 목 근육에 서방형 제재를 주입하였는데, 6회 투여구는 개시부터 2주까지는 100mg을, 3주부터 6주까지는 125mg을, 4회 투여구는 개시부터 2주까지는 100mg을, 3주부터 4주까지는 125mg을 투여하였다. 시험사료는 라이신 함량이 0.9%인 시판 육성돈사료를 무제한 급여한 결과 (주) LG 화학에서 제조한 서방출형 유전자재조합 pST는 증체량 및 사료요구율을 개선시켜 생산성 향상과 등지방두께 감소로 육질이 향상되었다.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제40권1호
• /
• pp.3-10
• /
• 2014

Objectives: Although nerve growth factor (NGF) could promote the functional regeneration of an injured peripheral nerve, it is very difficult for NGF to sustain the therapeutic dose in the defect due to its short half-life. In this study, we loaded the NGF-bound heparin-conjugated fibrin (HCF) gel in the NGF-delivering implants and analyzed the time-dependent release of NGF and its bioactivity to evaluate the clinical effectiveness. Materials and Methods: NGF solution was made of 1.0 mg of NGF and 1.0 mL of phosphate buffered saline (PBS). Experimental group A consisted of three implants, in which $0.25{\mu}L$ of NGF solution, $0.75{\mu}L$ of HCF, $1.0{\mu}L$ of fibrinogen and $2.0{\mu}L$ of thrombin was injected via apex hole with micropipette and gelated, were put into the centrifuge tube. Three implants of experimental group B were prepared with the mixture of $0.5{\mu}L$ of NGF solution, $0.5{\mu}L$ HCF, $1.0{\mu}L$ of fibrinogen and $2.0{\mu}L$ of thrombin. These six centrifuge tubes were filled with 1.0 mL of PBS and stirred in the water-filled beaker at 50 rpm. At 1, 3, 5, 7, 10, and 14 days, 1.0 mL of solution in each tubes was collected and preserved at $-20^{\circ}C$ with adding same amount of fresh PBS. Enzyme-linked immunosorbent assay (ELISA) was done to determine in vitro release profile of NGF and its bioactivity was evaluated with neural differentiation of pheochromocytoma (PC12) cells. Results: The average concentration of released NGF in the group A and B increased for the first 5 days and then gradually decreased. Almost all of NGF was released during 10 days. Released NGF from two groups could promote neural differentiation and neurite outgrowth of PC12 cells and these bioactivity was maintained over 14 days. Conclusion: Controlled release system using NGF-HCF gel via NGF-delivering implant could be an another vehicle of delivering NGF to promote the nerve regeneration of dental implant related nerve damage.